Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Plasmacytoma × Calcium Dobesilate × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 POEMS Syndrome 1 Neoplasm Metastasis 1 Brain Neoplasms 1

Interventions

ixazomib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Lenalidomide 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02921893 2025-02-12

Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome

Mayo Clinic

Phase EARLY_PHASE1 Completed

Plasmacytoma, POEMS Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡